Trade Mark Journal No.2026/028 10 July 2026
UK00004408039 26 June 2026 (35,41,42)
POINT LUMINA
- Class 35
- Business management and business organisation consultancy; business strategy consultancy; advisory services relating to organisational design, operating models, capability development and resource planning within pharmaceutical, biotechnology and healthcare organisations; business consultancy relating to the management, structure and operation of medical affairs functions; advisory services relating to product launch planning, lifecycle management and market engagement strategies for pharmaceutical, biotechnology and healthcare products; business consultancy relating to evidence strategy, real world evidence integration and data dissemination strategies within life sciences organisations.
- Class 41
- Education; providing of training; arranging and conducting conferences, seminars and workshops; provision of professional training and educational programmes for professionals working in the pharmaceutical, biotechnology and healthcare sectors; provision of educational courses and masterclasses relating to medical affairs, evidence generation and healthcare strategy; publication of educational and training materials in electronic form; coaching and professional development services for professionals working in medical affairs and healthcare organisations.
- Class 42
- Scientific consultancy; medical and scientific research consultancy; consultancy and advisory services relating to medical affairs strategy and evidence generation within the pharmaceutical, biotechnology and healthcare sectors; advisory services relating to the planning, generation, analysis and dissemination of medical and scientific evidence; consultancy relating to healthcare innovation, real world evidence and data driven decision making in healthcare and life sciences organisations; providing information and advisory services relating to the use of digital technologies and data analysis in medical affairs and healthcare research.
Point Lumina Medical Advisory Ltd
Representative: Harper James Ltd